Your browser doesn't support javascript.
loading
Prognostic significance of omental disease and the role of omentectomy in non-endometrioid endometrial cancer.
Seyfettinoglu, Sevtap; Khatib, Ghanim; Güleç, Ümran Küçükgöz; Güzel, Ahmet Baris; Gümürdülü, Derya; Vardar, Mehmet Ali.
Afiliação
  • Seyfettinoglu S; Department of Gynecology, Gynecologic Oncology, Adana City Training and Research Hospital, Türkiye, Türkiye. sevtaponcul@gmail.com.
  • Khatib G; Department of Gynecologic Oncology, Cukurova University, Adana, Türkiye, Türkiye.
  • Güleç ÜK; Department of Gynecologic Oncology, Cukurova University, Adana, Türkiye, Türkiye.
  • Güzel AB; Department of Gynecologic Oncology, Cukurova University, Adana, Türkiye, Türkiye.
  • Gümürdülü D; Faculty of Medicine, Department of Pathology, Cukurova University, Adana, Türkiye.
  • Vardar MA; Department of Gynecologic Oncology, Cukurova University, Adana, Türkiye, Türkiye.
Ginekol Pol ; 94(10): 823-830, 2023.
Article em En | MEDLINE | ID: mdl-37599572
ABSTRACT

OBJECTIVES:

Non-endometrioid endometrial cancers (non-EEC) have different management from endometrioid endometrial cancers. The purpose of this study was to investigate the prognostic significance of omental disease and the role of omentectomy in non-endometrioid endometrial cancer and discuss the current literature with the findings. MATERIAL AND

METHODS:

The study included two hundred-three patients with non-EEC who underwent surgical treatment and follow-up between January 1996 and December 2018 in a University Hospital Gynecologic Oncology Center. The patients were divided into three groups according to whether omentectomy was performed and the presence of omental metastasis. The patient's demographics, clinical characteristics such as stage, grade, histopathologic type, lymphovascular space invasion (LVSI), myometrial invasion, lymph node involvement, and survival outcomes were compared between the groups.

RESULTS:

The study included 203 patients. Twenty-five patients (12%) had omental metastases. LVSI was reported in 57.3%, 88.0%, and 43.2% of the non-omentectomy, no-omental metastasis, and omental metastatic groups, respectively (p = 0.001). The 5-year disease-free survival (DFS) and overall survival (OS) rates according to the tumor grade, peritoneal cytology, and lymphadenectomy were also compared and were found to be statistically similar. The five-year OS rates were 70.6% for the group without omental metastases and 16.2% for the group with omental metastases, respectively (p = 0.001). In the group of omentectomy, the five-year DFS rates were 62.2% in cases without omental metastasis and 13.0% in cases with omental metastasis (p = 0.001). The five-year OS rates of 86.3% and DFS rates of 80.0% in the group without omentectomy.

CONCLUSIONS:

In non-endometrioid tumors, the survival rate was better in the group that did not undergo omentectomy. Based on these results, we can say that omentectomy may not be necessary for non-endometrioid tumors whose omentum is found to be normal in intraoperative visual examination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias do Endométrio / Carcinoma Endometrioide Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ginekol Pol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias do Endométrio / Carcinoma Endometrioide Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ginekol Pol Ano de publicação: 2023 Tipo de documento: Article